Micron Biomedical

Carousel - Homepage

Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines

January 16, 2025

Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles

January 14, 2025

CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19 

January 8, 2025

Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World’s First Phase 2 Trial of Needle-Free Drug and Vaccine Technology in Infants

January 7, 2025

Micron Biomedical Recognized as a Breakthrough Scientific Innovation in the Prix Galien Start-Up Category

November 7, 2024

Micron Biomedical Wins the “Biotech Medical Innovation” Award at Boston Biotech Week

October 17, 2024